Cargando…
Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective
Non-small cell lung cancer is a prevalent and rapidly-expanding challenge to modern medicine. While generalized medicine with traditional chemotherapy yielded comparatively poor response rates and treatment results, the cornerstone of personalized medicine using genetic profiling to direct treatment...
Autores principales: | Jiang, Wenxiao, Cai, Guiqing, Hu, Peter C., Wang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089847/ https://www.ncbi.nlm.nih.gov/pubmed/30109178 http://dx.doi.org/10.1016/j.apsb.2018.04.005 |
Ejemplares similares
-
Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
por: Jiang, Wenxiao, et al.
Publicado: (2021) -
Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020) -
Pharmacogenomics: the promise of personalized medicine.
por: Hood, Ernie
Publicado: (2003) -
5. Pharmacogenomics and Personalized Medicine
por: Topić, Elizabeta
Publicado: (2008) -
Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?
por: Ciccacci, Cinzia, et al.
Publicado: (2019)